Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Prepares To Regulate LDTs, One Way Or The Other

Executive Summary

US FDA officials have said multiple times that they plan to move to regulate lab-developed tests, with or without Congressional action. And this week, the agency made a formal announcement of those intentions via the Unified Agenda.

You may also be interested in...



Diagnostics Reform Reintroduced in House

The VALID Act, which will hand diagnostics oversight to the US FDA, has been reintroduced in the House of Representatives after it failed twice last year in Congress.

'All Options On The Table,' Says Hillebrenner On Diagnostics Reform

During a recent webinar hosted by the Alliance for a Stronger FDA, Elizabeth Hillebrenner, associate director for scientific and regulatory programs at the agency’s device center, vowed to keep fighting for diagnostic reform despite Congress failing to pass the VALID Act last year.

Califf Sits Down For Fireside Chat; Looks Back And Ahead

Robert Califf marked his one-year anniversary as the commissioner of the US Food and Drug Administration by discussing the first year of his second term as the agency’s chief executive and his vision for the future.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148039

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel